Being a Caregiver June 3, 2022 A prostate cancer diagnosis can be devastating for you and your family, but you have options. At this confusing time, you may have questions about how to help ... Continue Reading
What is Active Surveillance May 27, 2022 Some prostate tumors grow very slowly and never cause health problems. Active surveillance or watchful waiting involves regular testing and monitoring. A... Continue Reading
Prostate Cancer Symptoms May 20, 2022 Early prostate cancer generally does not exhibit any symptoms. Oftentimes, an initial diagnosis is made by a doctor during an annual exam of the prostate. Men ... Continue Reading
What is a Gleason Score May 13, 2022 Pathologists review biopsy tissue and assign it a Gleason grade based on the appearance of the cells. If cancer is present, it will be assigned two Gleason gra... Continue Reading
Understanding PSA May 6, 2022 What is PSA? PSA is a protein (called prostate specific antigen) produced by cells that line the small... Continue Reading
Prostate cancer on the rise in 2022 April 29, 2022 Prostate cancer is a very common diagnosis. Did you know prostate cancer is estimated to be the second most common cancer diagnosis in American men?According ... Continue Reading
Genetic insights for more actionable and personalized prostate cancer March 25, 2022 Connect with us The AUA National meeting is centered around the exploration of the latest and groundbreaking advancements in urology, and th... Continue Reading
Prolaris® is advancing prostate cancer care at ASCO GU February 11, 2022 Prolaris now has 2 validated thresholds to make treatment decisions easier Prolaris is a prognostic, tumor-based biomarker test that measures the aggressive... Continue Reading
Prolaris® is Helping Urologists Reimagine Prostate Cancer Care November 2, 2021 This year’s LUGPA theme centers on re-imagining the practice of Urology. What better time than now to discover how incorporating genetic testing into your pr... Continue Reading
New Study Proves that Prolaris can Determine which Patients Can Safely Avoid ADT October 15, 2021 Historically, Urologists in practice have given Radiation Therapy (RT) or Androgen Deprivation Therapy (ADT) after initial prostate cancer treatment to red... Continue Reading
2021 Prostate Cancer Statistics April 15, 2021 According to the American Cancer Society, the number of newly diagnosed prostate cancer patients has increased by nearly 30% since 2020 and estimates there wil... Continue Reading
New Data Validating the Prolaris® Test to Guide Treatment for Prostate Cancer February 17, 2021 Myriad Genetics announces new data validating the prognostic power of the Prolaris multi-modal threshold and its ability to help predict which men with agg... Continue Reading
The Importance of Genetic Testing for Prostate Cancer P2 September 28, 2020 In the second webinar installment partnered with Prostate Health Education Network (PHEN), Dr. Keith Crawford MD, PHD will discuss new treatment and clinical t... Continue Reading
The Importance of Genetic Testing for Prostate Cancer P1 September 17, 2020 Myriad has partnered with the Prostate Health Education Network (PHEN) advocacy group to help educate patients and caregivers on the importance of genetic test... Continue Reading
1 in 6 Men with Prostate Cancer May Have a Hereditary, Disease-Causing Mutation September 17, 2020 Knowing the status of your patient’s BRCA 1/2 germline status is critical. Myriad hereditary cancer tests give you definitive and actionable risk stratificat... Continue Reading